AlphaCore Capital’s DexCom DXCM Stock Holding History

AlphaCore Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$545K	Buy	8,095 +1,824	+29%	+$122K	0.01%	651
2026 Q1	$394K	Buy	+6,271	New	+$437K	0.01%	615

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AlphaCore Capital's DXCM Position: Q2 2026 in Review

AlphaCore Capital increased its DexCom (DXCM) stake by 29% in Q2 2026, buying an estimated $122K and bringing the position to 8,095 shares worth $545K. The position accounts for 0.01% of the portfolio, ranked #651.

AlphaCore Capital first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

AlphaCore Capital held 8,095 shares of DexCom worth $545K as of Q2 2026.
AlphaCore Capital bought 1,824 DexCom shares in Q2 2026, an estimated $122K.
DexCom made up 0.01% of AlphaCore Capital's portfolio in Q2 2026, its #651 holding.
AlphaCore Capital first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.